Results 11 to 20 of about 527 (123)

A European field assessment of the efficacy of fluralaner (Bravecto®) chewable and spot-on formulations for treatment of dogs with generalized demodicosis [PDF]

open access: yesParasites & Vectors, 2020
Background Recent reports indicate that the isoxazoline compounds have the potential to provide safe and effective treatment of canine generalized demodicosis, a condition that has been traditionally difficult to cure. Controlled field studies are needed
Ivo Petersen   +6 more
doaj   +2 more sources

A new species of Demodex (Acari: Demodecidae) with data on topical specificity and topography of demodectic mites in the striped field mouse Apodemus agrarius (Rodentia: Muridae).

open access: greenJournal of medical entomology, 2014
This article describes morphological characteristics and the occurrence of Demodex gracilentus sp. nov., which was found in the striped field mouse Apodemus agrarius (Pallas, 1771) in the skin of vibrissae area. D. gracilentus occurred in 36.7% of the rodents examined. D.
Joanna N, Izdebska, Leszek, Rolbiecki
  +6 more sources

Reducing ocular Demodex using petroleum jelly may alleviate dry eye syndrome, blepharitis, facial dermatoses, ocular and respiratory allergies, and decrease associated prescribing: a hypothesis [PDF]

open access: yesFrontiers in Allergy
Demodex eyelash mites are increasingly associated with eye and skin inflammation in humans, and cause demodectic mange in mammals. Informal accounts of symptom improvement and reduced need for anti-allergy medicines, when Demodex reproduction is ...
Diana E. Senior-Fletcher   +1 more
doaj   +2 more sources

Demodectic Mites of Subhuman Primates I: Demodex saimiri sp. n. (Acari: Demodicidae) from the Squirrel Monkey, Saimiri sciureus

open access: hybridThe Journal of Parasitology, 1973
A new mite species, Demodex saimiri, is described from the squirrel monkey, Saimiri sciureus. All stages are found in the hair follicles and sebaceous glands. Adults and immatures consume cells of the follicular epithelium and/or sebaceous glands. An incidence of 57% is reported, with 67% incidence in female and 47% in male host animals.
R R, Lebel, W B, Nutting
openaire   +3 more sources

Efficacy of topically administered fluralaner or imidacloprid/moxidectin on dogs with generalised demodicosis [PDF]

open access: yesParasites & Vectors, 2019
Background Canine demodicosis is classified as localised or generalised according to the extent of the disease. Chronic generalised demodicosis is a difficult skin disease to treat and unlikely to resolve without therapy.
Josephus J. Fourie   +2 more
doaj   +2 more sources

Evaluation of the Efficacy of Tea Tree Oil On the Density ofDemodexMites (Acari: Demodicidae) and Ocular Symptoms In Patients With Demodectic Blepharitis

open access: closedJournal of Parasitology, 2018
The objective of this study was to examine the efficacy of 7.5% tea tree oil (TTO) eyelash shampoo on the density of Demodex (Acari: Demodicidae) and ocular symptoms in patients with demodectic blepharitis. A total of 135 patients diagnosed with demodectic blepharitis, following clinical inspection and parasitological examinations, were included in the
Karakurt, Yücel, Zeytun, Erhan
openaire   +4 more sources

Critically appraised topic for the most effective and safe treatment for canine generalised demodicosis. [PDF]

open access: yesBMC Vet Res, 2019
Background Canine generalised demodicosis is an inflammatory parasitic skin disease caused by an excessive proliferation of Demodex spp. Generalized demodicosis is a severe skin disease, that can be life threatening if not treated properly.
Perego R, Spada E, Foppa C, Proverbio D.
europepmc   +3 more sources

IgE AND IgG antibody responses to Dermatophagoides pteronyssinus in dogs with demodicosis and atopic dermatitis

open access: yesBioscience Journal, 2020
Canine demodicosis is a common inflammatory parasitic skin disease caused by Demodex mites. House dust mites, such as Dermatophagoides spp., play an important role in the pathogenesis of canine atopic dermatitis (AD).
Maria Cecília Oliveira   +9 more
doaj   +3 more sources

A masked, randomised clinical trial evaluating the efficacy and safety of lokivetmab compared to saline control in client‐owned dogs with allergic dermatitis

open access: yesVeterinary Dermatology, Volume 32, Issue 5, Page 477-e131, October 2021., 2021
Background – Interleukin (IL)‐31 is an important mediator in canine atopic dermatitis (cAD) and also may be dysregulated in other allergic diseases. Hypothesis/Objectives – To demonstrate the efficacy and safety of lokivetmab (canine anti‐IL‐31 monoclonal antibody) for treatment of pruritus associated with allergic dermatitis in dogs.
Leen Van Brussel   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy